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Primary leiomyosarcomas of vascular origin are rare tumors. They frequently arise within the inferior vena cava; however, the
peripheral vein was also affected. To date, only a few hundred cases have been reported in the world literature. Although it is an
extremely aggressive tumor, the symptoms may be unspecific, especially in the lower extremities. In this report, we present a
case of primary vascular leiomyosarcoma, arising from the short saphenous vein, with symptoms mimicking thrombus in the
initial diagnosis. The diagnosis of leiomyosarcomas was confirmed by standard H&E staining and immunohistochemical
staining. Recurrence of the tumor has been observed five years after surgical treatment. Due to its rarity, experience in the
management of this type of tumor is limited. The mainstay of treatment for these tumors is complete surgical resection. The
purpose of the presented case is to discuss the clinicopathological features and management options of this tumor, under the
light of the most recent literatures.
1. Introduction
Primary tumors arising from the vessel wall are rare.
Although primary vascular leiomyosarcoma (vLMS) arising
from larger blood vessels (particularly in the inferior vena
cava and large veins of the lower extremity) has been
reported [1], leiomyosarcoma originating from a peripheral
vein is exceptional. A case of primary vLMS of the short
saphenous vein has been described in 1998 [2]. Herein, we
report a vLMS primarily localized within the wall of the short
saphenous vein, which is, to the best of our knowledge, the
second presented in the medical literature.
2. Report of a Patient
A 58-year-old woman was admitted to a cardiovascular sur-
gery clinic for the evaluation of a painless mass in her left
leg and lower extremity edema with a three-week duration
of history in August 2008. Physical examination showed a
mass was palpable deep to the skin in the course of the short
saphenous vein. No other skin lesions and no systemic man-
ifestations were found. Routine laboratory studies were unre-
markable. Ultrasonography detected a luminal mass in the
short saphenous vein. A magnetic resonance imaging
(MRI) revealed a 15× 10× 7mm heterogeneous mass extend-
ing into the Achilles tendon, which may be related to the
thrombosis of the short saphenous vein. The mass was
excised en bloc under tourniquet control with a safe margin.
Vascular reconstruction was not performed. The gross spec-
imen consisted of the saphenous vein was surrounded and
infiltrated by a whitish to brownish, rubbery tissue all along
its course, measuring 3.5× 2× 1.5 cm. Microscopic examina-
tion showed a tumor was arising from the vascular wall
(Figure 1) and composed of spindle-shaped cells, arranged
in intersecting fascicles, with fusiform nuclei displaying mod-
erate atypia with hyperchromasia, nuclear enlargement, and
occasional giant cells (Figure 2). Mitotic count varied
between 7 and 8 per 10 high-power fields, with occasional
atypical mitotic figures. Immunohistochemically, the tumor
showed strong and diffuse reactivity for smooth muscle actin
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and focal and moderate reactivity for desmin and caldes-
mon. The proliferation index detected by Ki-67 was found
to be 20%. The immunostains for S-100 and CD34 were neg-
ative. At the time of diagnosis, the patient has no metastasis.
Postoperatively, the wound healed well with normal extrem-
ity function. Although the patient was referred to an oncol-
ogist to plan the follow-up strategy but, she denied. The
patient was medically well in 5 years, but at the end of the
five-year period, she was readmitted with local recurrence.
After the reoperation, the patient received adjuvant radio-
therapy and chemotherapy. She underwent regular controls
at the Department of Oncology, she remains alive and, in
her last following period, there was no evidence of metastasis
or local recurrence.
3. Discussion
Leiomyosarcomas of soft tissue generally present retroperito-
neum; however, it is the predominant sarcoma arising from
blood vessels. vLMS more commonly arises from the venous,
rather than arterial vessels. It is reported that the long saphe-
nous vein is the most affected vein and followed by the fem-
oral vein and popliteal vein in the lower extremity [3]. On the
other hand, there are case series pointing out that the major-
ity of tumors were from the femoral vein [4, 5]. This is, to our
knowledge, the second case of primary vLMS of the short
saphenous vein. The first one was published in 1986 by Leu
and Makek [2].
The symptoms are related to the location of the tumor,
rate of tumor growth, and degree of collateral blood flow.
They most commonly present as slow-growing, painless
masses. When the tumor is occlusive, the symptoms can
mimic those of deep vein thrombosis [6, 7]. In addition, in
the initial radiologic evaluation, the tumor is often misdiag-
nosed as a deep vein thrombosis, similar to what occurred
in our case. Abed et al. reported that most patients had been
thought to have deep venous thrombosis resulting in diag-
nostic delay [4]. Cross-sectional imaging with contrast-
enhanced CT or MRI is recommended in differentiating
intravascular tumor growth from thrombosis; however, find-
ings may be nonspecific [8, 9].
Histological tumor was composed of spindle-shaped cells
with an eosinophilic cytoplasm with muscular striation and
cigar-shaped rounded nuclei. We applied immunohisto-
chemical staining for smooth muscle markers such as actin
and desmin as well as h-caldesmon to verify the diagnosis.
The differential diagnosis includes spindle cell-shaped neo-
plasms such as benign and malignant tumors of the nerve
sheaths, myofibroblastic tumors (myofibromatosis, fibro-
matosis, and myofibroblastic sarcoma), synovial sarcoma,
and fibrosarcoma.
Leiomyosarcomas have clinical and biologic differences
according to site-related subgroups. Although leiomyosarco-
mas of the retroperitoneum and abdominal cavity are associ-
ated with an aggressive clinical course, the behavior of the
primary vLMS has been controversial. Leu and Makek
reported that small vLMSs might have relatively good prog-
nosis [2]; however, Berlin et al. reported metastases, even
with relatively low mitotic rates of tumor [10]. Italiano
et al. determined that vLMS had a significantly worse median
metastasis-free survival and an overall survival than leiomyo-
sarcomas of other origins [11]. The more aggressive behavior
and worse prognosis of vLMSs could be due to a direct attack
to the vascular system [1]. However, in another study com-
paring the prognosis of vLMS with leiomyosarcoma other
anatomic sites, authors reported that vLMS of extremity has
similar prognosis to leiomyosarcoma of different origins [12].
Operation is the mainstay of treatment for vLMSs. The
role of neo-adjuvant chemotherapy (CT) and radiotherapy
(RT) in the management of disease is still unknown. The rate
of local recurrence was not significantly different between
patients who received perioperative RT and those who did
not [13]. Similarly, Italiano et al. showed that RT has only a
limited role in the management of vLMSs and they founded
that 75% of patients died of metastatic disease within the first
3 years of diagnosis, although good local control by surgery
and RT was achieved [11]. CT was mostly offered to treat
metastasis; however, its advantages have not been well docu-
mented [14]. The authors reported that neither systemic CT
nor chemoembolization or radiofrequency has improved the
overall survival or disease-free survival [14, 15].
Although there has been local recurrence in the five-year
period, the present case seems to be a good prognosis. The
review revealed that the survival of the deceased patients with
the vLMS of the popliteal artery was between 7 months and 4
years [16]. Reix et al. described a series of six patients with a
leiomyosarcoma and one with hemangioendothelioma. In
Figure 1: Tumor was arising from the vascular wall and protrude to
lumen H&E 10x.
Figure 2: The histological section shows atypical tumor cells with
fasciculated and interlacing pattern. H&E 40x.
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their series, the median survival was reported as 31 months
[5]. Marle et al. reported that the average survival was 4 years
(range 1 month to 17 years) [17]. In those studies, the major-
ity of patients with vLMS have metastatic disease at the time
of resection. In the present case, the patient was still alive 60
months following reoperation of recurrent tumor. We
thought that this finding may be associated with the localized
disease of our patient.
In conclusion, vLMSs of extremity are rare and aggressive
tumors. Clinicians should consider that it may be misdiag-
nosed as deep vein thrombosis in the initial diagnosis. The
management of these tumors is surgical treatment; however,
considering the local recurrence in our patient, radiation
therapy and chemotherapy should have been considered.
Due to its rare incidence, all publications in the literature
are of small clinical series or case reports. Therefore, we
thought that our case report also provides data to the litera-
ture for the management of vLMS.
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